• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对神经肽痛敏肽/孤啡肽具有拮抗特性的生物稳定适体。

Biostable aptamers with antagonistic properties to the neuropeptide nociceptin/orphanin FQ.

作者信息

Faulhammer Dirk, Eschgfäller Bernd, Stark Sandra, Burgstaller Petra, Englberger Werner, Erfurth Jeannette, Kleinjung Frank, Rupp Johanna, Dan Vulcu Sebastian, Schröder Werner, Vonhoff Stefan, Nawrath Hermann, Gillen Clemens, Klussmann Sven

机构信息

NOXXON Pharma AG, 10589 Berlin, Germany.

出版信息

RNA. 2004 Mar;10(3):516-27. doi: 10.1261/rna.5186504.

DOI:10.1261/rna.5186504
PMID:14970396
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1370946/
Abstract

The neuropeptide nociceptin/orphanin FQ (N/OFQ), the endogenous ligand of the opioid receptor-like 1 (ORL1) receptor, has been shown to play a prominent role in the regulation of several biological functions such as pain and stress. Here we describe the isolation and characterization of N/OFQ binding biostable RNA aptamers (Spiegelmers) using a mirror-image in vitro selection approach. Spiegelmers are L-enantiomeric oligonucleotide ligands that display high affinity and specificity to their targets and high resistance to enzymatic degradation compared to D-oligonucleotides. A representative Spiegelmer from the selections performed was size-minimized to two distinct sequences capable of high affinity binding to N/OFQ. The Spiegelmers were shown to antagonize binding of N/OFQ to the ORL1 receptor in a binding-competition assay. The calculated IC(50) values for the Spiegelmers NOX 2149 and NOX 2137a/b were 110 nM and 330 nM, respectively. The competitive antagonistic properties of these Spiegelmers were further demonstrated by their effective and specific inhibition of G-protein activation in two additional models. The Spiegelmers antagonized the N/OFQ-induced GTPgammaS incorporation into cell membranes of a CHO-K1 cell line expressing the human ORL1 receptor. In oocytes from Xenopus laevis, NOX 2149 showed an antagonistic effect to the N/OFQ-ORL 1 receptor system that was functionally coupled with G-protein-regulated inwardly rectifying K(+) channels.

摘要

神经肽痛敏肽/孤啡肽FQ(N/OFQ)是阿片样物质受体1(ORL1)的内源性配体,已被证明在调节疼痛和应激等多种生物学功能中发挥重要作用。在此,我们描述了使用镜像体外筛选方法分离和鉴定N/OFQ结合生物稳定RNA适配体(镜像寡核苷酸)的过程。镜像寡核苷酸是L-对映体寡核苷酸配体,与D-寡核苷酸相比,它们对其靶标显示出高亲和力和特异性,并且对酶促降解具有高抗性。从所进行的筛选中选出的一个代表性镜像寡核苷酸被最小化至两个能够与N/OFQ高亲和力结合的不同序列。在结合竞争试验中,这些镜像寡核苷酸被证明可拮抗N/OFQ与ORL1受体的结合。镜像寡核苷酸NOX 2149和NOX 2137a/b的计算IC50值分别为110 nM和330 nM。在另外两个模型中,这些镜像寡核苷酸对G蛋白激活的有效且特异性抑制进一步证明了它们的竞争性拮抗特性。这些镜像寡核苷酸拮抗了N/OFQ诱导的GTPγS掺入表达人ORL1受体的CHO-K1细胞系的细胞膜中。在非洲爪蟾的卵母细胞中,NOX 2149对与G蛋白调节的内向整流钾通道功能偶联的N/OFQ-ORL 1受体系统表现出拮抗作用。

相似文献

1
Biostable aptamers with antagonistic properties to the neuropeptide nociceptin/orphanin FQ.对神经肽痛敏肽/孤啡肽具有拮抗特性的生物稳定适体。
RNA. 2004 Mar;10(3):516-27. doi: 10.1261/rna.5186504.
2
Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications.孤啡肽/痛敏肽受体:药理学及临床意义
Curr Drug Targets. 2007 Jan;8(1):117-35. doi: 10.2174/138945007779315605.
3
The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.与肥胖、应激、焦虑、情绪和药物依赖有关的孤啡肽/Nociceptin(N/OFQ)的生物学。
Pharmacol Ther. 2014 Mar;141(3):283-99. doi: 10.1016/j.pharmthera.2013.10.011. Epub 2013 Nov 1.
4
Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor.孤啡肽/痛敏肽与阿片受体样ORL1受体
Eur J Pharmacol. 1997 Dec 4;340(1):1-15. doi: 10.1016/s0014-2999(97)01411-8.
5
Interaction of [3H]orphanin FQ and 125I-Tyr14-orphanin FQ with the orphanin FQ receptor: kinetics and modulation by cations and guanine nucleotides.[3H]孤啡肽FQ与125I-酪氨酸14-孤啡肽FQ与孤啡肽FQ受体的相互作用:动力学以及阳离子和鸟嘌呤核苷酸的调节作用
Mol Pharmacol. 1997 May;51(5):816-24. doi: 10.1124/mol.51.5.816.
6
Comparison of the binding of [(3)H]nociceptin/orphaninFQ(1-13)NH(2), [(3)H]nociceptin/orphaninFQ(1-17)OH and [(125)I]Tyr(14)nociceptin/orphaninFQ(1-17)OH to recombinant human and native rat cerebrocortical nociceptin/orphanin FQ receptors.[(3)H]孤啡肽/孤啡肽FQ(1 - 13)NH(2)、[(3)H]孤啡肽/孤啡肽FQ(1 - 17)OH和[(125)I]酪氨酸(14)孤啡肽/孤啡肽FQ(1 - 17)OH与重组人类和天然大鼠脑皮质孤啡肽/孤啡肽FQ受体结合的比较
Neurosci Lett. 2002 Aug 2;328(1):5-8. doi: 10.1016/s0304-3940(02)00259-8.
7
Binding of the novel radioligand [(3)H]UFP-101 to recombinant human and native rat nociceptin/orphanin FQ receptors.新型放射性配体[(3)H]UFP-101与重组人源及天然大鼠孤啡肽/孤啡肽FQ受体的结合
Naunyn Schmiedebergs Arch Pharmacol. 2008 Dec;378(6):553-61. doi: 10.1007/s00210-008-0350-3. Epub 2008 Sep 21.
8
Binding and GTPgammaS autoradiographic analysis of preproorphanin precursor peptide products at the ORL1 and opioid receptors.在阿片受体样1受体(ORL1)和阿片受体处对前阿片原蛋白前体肽产物进行结合和GTPγS放射自显影分析。
J Chem Neuroanat. 2003 Jul;25(4):233-47. doi: 10.1016/s0891-0618(03)00032-2.
9
[Phe1psi(CH2-NH)Gly2]nociceptin-(1 - 13)-NH2 activation of an inward rectifier as a partial agonist of ORL1 receptors in rat periaqueductal gray.[苯丙氨酸1ψ(CH2-NH)甘氨酸2]强啡肽原-(1 - 13)-NH2作为大鼠中脑导水管周围灰质中孤啡肽受体1的部分激动剂激活内向整流器。
Br J Pharmacol. 1999 Sep;128(1):103-7. doi: 10.1038/sj.bjp.0702746.
10
Nociceptin (ORL-1) and mu-opioid receptors mediate mitogen-activated protein kinase activation in CHO cells through a Gi-coupled signaling pathway: evidence for distinct mechanisms of agonist-mediated desensitization.孤啡肽(ORL-1)和μ-阿片受体通过Gi偶联信号通路介导CHO细胞中的丝裂原活化蛋白激酶激活:激动剂介导的脱敏的不同机制的证据。
J Neurochem. 1998 Sep;71(3):1024-33. doi: 10.1046/j.1471-4159.1998.71031024.x.

引用本文的文献

1
Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer.超声介导的纳米泡破坏(UMND)促进了靶向 A10-3.2 适体和载有 siRNA 的阳离子纳米泡的递送来治疗前列腺癌。
Drug Deliv. 2018 Nov;25(1):226-240. doi: 10.1080/10717544.2017.1422300.
2
Nucleic Acid Aptamers: Emerging Applications in Medical Imaging, Nanotechnology, Neurosciences, and Drug Delivery.核酸适体:在医学成像、纳米技术、神经科学和药物输送中的新兴应用。
Int J Mol Sci. 2017 Nov 16;18(11):2430. doi: 10.3390/ijms18112430.
3
Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide--glycolic acid) nanobubbles for ultrasound imaging and therapy of prostate cancer.负载紫杉醇且靶向A10-3.2适配体的聚(丙交酯-乙交酯)纳米泡用于前列腺癌的超声成像与治疗
Int J Nanomedicine. 2017 Jul 26;12:5313-5330. doi: 10.2147/IJN.S136032. eCollection 2017.
4
In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies.化学修饰核酸适配体的体外进化:利弊与综合筛选策略
RNA Biol. 2016 Dec;13(12):1232-1245. doi: 10.1080/15476286.2016.1236173. Epub 2016 Oct 7.
5
Capillary electrophoresis-SELEX selection of catalytic DNA aptamers for a small-molecule porphyrin target.毛细管电泳-SELEX 法筛选小分子卟啉靶标的催化 DNA 适体。
Anal Chem. 2013 Feb 5;85(3):1525-30. doi: 10.1021/ac302721j. Epub 2013 Jan 14.
6
Aptamers as therapeutics.适配子疗法。
Nat Rev Drug Discov. 2010 Jul;9(7):537-50. doi: 10.1038/nrd3141.
7
In vitro selection using a dual RNA library that allows primerless selection.使用允许无引物选择的双RNA文库进行体外筛选。
Nucleic Acids Res. 2006 Jul 19;34(12):e86. doi: 10.1093/nar/gkl463.
8
Inhibition of stimulated meningeal blood flow by a calcitonin gene-related peptide binding mirror-image RNA oligonucleotide.降钙素基因相关肽结合镜像RNA寡核苷酸对刺激的脑膜血流的抑制作用。
Br J Pharmacol. 2006 Jun;148(4):536-43. doi: 10.1038/sj.bjp.0706742. Epub 2006 Apr 24.
9
In vivo biodistribution and pharmacokinetics of 18F-labelled Spiegelmers: a new class of oligonucleotidic radiopharmaceuticals.18F标记的 Spiegelmers 的体内生物分布与药代动力学:一类新型的寡核苷酸放射性药物
Eur J Nucl Med Mol Imaging. 2005 Apr;32(4):470-7. doi: 10.1007/s00259-004-1669-8. Epub 2004 Dec 22.

本文引用的文献

1
Toward third-generation aptamers: Spiegelmers and their therapeutic prospects.迈向第三代适配体:镜像异寡核苷酸及其治疗前景。
Curr Opin Drug Discov Devel. 2003 Mar;6(2):253-61.
2
GnRH binding RNA and DNA Spiegelmers: a novel approach toward GnRH antagonism.促性腺激素释放激素结合RNA和DNA Spiegelmers:一种促性腺激素释放激素拮抗的新方法。
Chem Biol. 2002 Mar;9(3):351-9. doi: 10.1016/s1074-5521(02)00111-4.
3
Pharmacological profile of nociceptin/orphanin FQ receptors.孤啡肽/痛敏肽受体的药理学特性
Clin Exp Pharmacol Physiol. 2002 Mar;29(3):223-8. doi: 10.1046/j.1440-1681.2002.03633.x.
4
The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family.孤啡肽/痛敏肽肽及受体家族的分子与行为药理学
Pharmacol Rev. 2001 Sep;53(3):381-415.
5
Aptamers: selected oligonucleotides for therapy.适配体:用于治疗的筛选寡核苷酸。
Curr Opin Mol Ther. 2000 Jun;2(3):318-24.
6
Voltage dependence of L-arginine transport by hCAT-2A and hCAT-2B expressed in oocytes from Xenopus laevis.非洲爪蟾卵母细胞中表达的hCAT - 2A和hCAT - 2B对L - 精氨酸转运的电压依赖性
Am J Physiol Cell Physiol. 2000 Nov;279(5):C1336-44. doi: 10.1152/ajpcell.2000.279.5.C1336.
7
Species differences in the efficacy of compounds at the nociceptin receptor (ORL1).化合物对孤啡肽受体(ORL1)作用效果的种属差异。
Peptides. 2000 Jul;21(7):1147-54. doi: 10.1016/s0196-9781(00)00253-9.
8
Agonistic effects of the opioid buprenorphine on the nociceptin/OFQ receptor.阿片类药物丁丙诺啡对孤啡肽/孤啡肽FQ受体的激动作用。
Peptides. 2000 Jul;21(7):1141-6. doi: 10.1016/s0196-9781(00)00252-7.
9
Functional studies using antibodies against orphanin FQ/nociceptin.使用抗孤啡肽/痛敏肽抗体的功能研究。
Peptides. 2000 Jul;21(7):1047-50. doi: 10.1016/s0196-9781(00)00242-4.
10
Effects of supraspinal orphanin FQ/nociceptin.脊髓上孤啡肽/痛敏肽的作用
Peptides. 2000 Jul;21(7):1037-45. doi: 10.1016/s0196-9781(00)00236-9.